openPR Logo

Press Releases from DelveInsight Business Research LLP (4862 total)

Bladder Cancer Pipeline Drugs, FDA Approvals, and Companies 2024

DelveInsight's, "Bladder Cancer Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers

Biliary Tract Cancers Pipeline Drugs, FDA Approvals, and Companies 2024

DelveInsight's, "Biliary Tract Cancers Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Biliary Tract Cancers Pipeline landscape.

Pancreatic Cancer Pipeline Drugs, FDA Approvals, and Companies 2024

DelveInsight's, "Pancreatic Cancer Pipeline Insight 2024" report provides comprehensive insights about 290+ companies and 300+ pipeline drugs in the Pancreatic Cancer pipeline landscape. It covers

Breast Cancer Pipeline Drugs, FDA Approvals, and Companies 2024

DelveInsight's, "Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 120+ Breast Cancer companies and 130+ pipeline drugs in the Breast Cancer pipeline landscape.

Esophageal Cancer Pipeline Drugs, FDA Approvals, and Companies 2024

DelveInsight, "Esophageal Cancer Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Esophageal Cancer pipeline landscape. It covers

Diffuse Large B-Cell Lymphoma Pipeline Drugs, FDA Approvals, and Companies 2024

DelveInsight's, "Diffuse Large B-Cell Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline

Esophageal Squamous Cell Carcinoma Pipeline Drugs, FDA Approvals, and Companies …

DelveInsight's, "Esophageal Squamous Cell Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Esophageal Squamous Cell Carcinoma pipeline

Cutaneous Squamous Cell Carcinoma Pipeline Drugs, FDA Approvals, and Companies 2 …

DelveInsight's, "Cutaneous Squamous Cell Carcinoma Pipeline Insight, 2024" report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Cutaneous Squamous Cell Carcinoma pipeline

Squamous Cell Carcinoma Pipeline Drugs, FDA Approvals, and Companies 2024

DelveInsight's, "Squamous Cell Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Squamous Cell Carcinoma pipeline landscape. It

Pancreatic Ductal Adenocarcinoma Pipeline Drugs, FDA Approvals, and Companies 20 …

DelveInsight's, "Pancreatic Ductal Adenocarcinoma Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Pancreatic Ductal Adenocarcinoma pipeline landscape. It

Netherton Syndrome Pipeline Drugs, FDA Approvals, and Companies 2024

DelveInsight's, "Netherton Syndrome- Pipeline Insight, 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Netherton Syndrome pipeline landscape. It covers the

Dengue Pipeline Drugs, FDA Approvals, and Companies 2024

DelveInsight's, "Dengue- Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Dengue pipeline landscape. It covers the Dengue pipeline

ANCA Vasculitis Pipeline Drugs, FDA Approvals, and Companies 2024

DelveInsight's, "ANCA Vasculitis Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in ANCA Vasculitis pipeline landscape. It covers the

Idiopathic Pulmonary Fibrosis Pipeline Drugs, FDA Approvals, and Companies 2024

DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Idiopathic Pulmonary Fibrosis pipeline landscape. It

Soft Tissue Sarcoma Pipeline Drugs, FDA Approvals, and Companies 2024

DelveInsight's, "Soft Tissue Sarcoma Pipeline Insight 2024" report provides comprehensive insights about 125+ companies and 130+ pipeline drugs in Soft Tissue Sarcoma pipeline landscape. It

Seborrhoeic Dermatitis Clinical Trials | A Drug Pipeline Analysis Report 2024 | …

DelveInsight's 'Seborrhoeic Dermatitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Seborrhoeic Dermatitis therapies in various stages of clinical development,

Secondary Progressive Multiple Sclerosis Clinical Trials | A Drug Pipeline Analy …

DelveInsight's 'Secondary Progressive Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Secondary Progressive Multiple Sclerosis therapies in various

Sensorineural Hearing Loss Clinical Trials | A Drug Pipeline Analysis Report 202 …

DelveInsight's 'Sensorineural Hearing Loss Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sensorineural Hearing Loss therapies in various stages of

Raynaud's Disease Clinical Trials, Key Companies, Emerging Therapies | A Drug Pi …

DelveInsight's 'Raynaud's Disease Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Raynaud's Disease therapies in various stages of clinical development,

Ulcerative Colitis Clinical Trials | A Drug Pipeline Analysis Report 2024 | Oppi …

DelveInsight's 'Ulcerative Colitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Ulcerative Colitis therapies in various stages of clinical development,

Adult Growth Hormone Deficiency Market to Grow Positively at a Paltry CAGR Durin …

DelveInsight's "Adult Growth Hormone Deficiency - Market Insight, Epidemiology and Market Forecast - 2032" report provides current treatment practices, emerging drugs, Adult Growth Hormone Deficiency

Advanced Cancer Pain Management Market to Grow Positively at a Paltry CAGR Durin …

United States, Nevada, Las Vegas, DelveInsight's "Advanced Cancer Pain Management - Market Insight, Epidemiology and Market Forecast - 2032" report provides current treatment practices, emerging

Refractory Angina Market to Grow Positively at a Paltry CAGR During the Study Pe …

DelveInsight's "Refractory Angina - Market Insight, Epidemiology and Market Forecast - 2034" report provides current treatment practices, emerging drugs, Refractory Angina market share of the

Advanced Renal Cell Carcinoma Market to Grow Positively at a Paltry CAGR During …

DelveInsight's "Advanced Renal Cell Carcinoma - Market Insight, Epidemiology and Market Forecast - 2032" report provides current treatment practices, emerging drugs, Advanced Renal Cell Carcinoma

Age Related Macular Degeneration Market to Grow Positively at a Paltry CAGR Duri …

DelveInsight's "Age Related Macular Degeneration - Market Insight, Epidemiology and Market Forecast - 2034" report provides current treatment practices, emerging drugs, Age Related Macular Degeneration

Recurrent Glioblastoma Market to Grow Positively at a Paltry CAGR During the Stu …

DelveInsight's "Recurrent Glioblastoma - Market Insight, Epidemiology and Market Forecast - 2032" report provides current treatment practices, emerging drugs, Recurrent Glioblastoma market share of the

Al Amyloidosis Market to Grow Positively at a Paltry CAGR During the Study Perio …

DelveInsight's "Al Amyloidosis - Market Insight, Epidemiology and Market Forecast - 2032" report provides current treatment practices, emerging drugs, Al Amyloidosis market share of the

Alagille Syndrome Market to Grow Positively at a Paltry CAGR During the Study Pe …

DelveInsight's "Alagille Syndrome - Market Insight, Epidemiology and Market Forecast - 2032" report provides current treatment practices, emerging drugs, Alagille Syndrome market share of the

Pseudoxanthoma Elasticum Market to Grow Positively at a Paltry CAGR During the S …

DelveInsight's "Pseudoxanthoma Elasticum - Market Insight, Epidemiology and Market Forecast - 2034" report provides current treatment practices, emerging drugs, Pseudoxanthoma Elasticum market share of the

Psoriasis Market to Grow Positively at a Paltry CAGR During the Study Period | A …

DelveInsight's "Psoriasis - Market Insight, Epidemiology and Market Forecast - 2034" report provides current treatment practices, emerging drugs, Psoriasis market share of the individual therapies,

Adrenal Crisis Market to Grow Positively at a Significant CAGR, asserts DelveIns …

DelveInsight's "Adrenal Crisis - Market Insight, Epidemiology and Market Forecast - 2034" report provides current treatment practices, emerging drugs, Adrenal Crisis market share of the

Sarcopenia Market to Grow Positively at a Paltry CAGR During the Study Period (2 …

DelveInsight's "Sarcopenia - Market Insight, Epidemiology and Market Forecast - 2034" report provides current treatment practices, emerging drugs, Sarcopenia market share of the individual therapies,

Autosomal Dominant Polycystic Kidney Disease Market to Grow Positively at a Palt …

DelveInsight's "Autosomal Dominant Polycystic Kidney Disease - Market Insight, Epidemiology and Market Forecast - 2034" report provides current treatment practices, emerging drugs, Autosomal Dominant Polycystic

Adenoid Cystic Carcinoma Market to Grow Positively at a Paltry CAGR During the S …

DelveInsight's "Adenoid Cystic Carcinoma - Market Insight, Epidemiology and Market Forecast - 2032" report provides current treatment practices, emerging drugs, Adenoid Cystic Carcinoma market share

Adeno Associated Virus Vectors In Gene Therapy Market to Grow Positively at a Pa …

DelveInsight's "Adeno Associated Virus Vectors In Gene Therapy - Market Insight, Epidemiology and Market Forecast - 2034" report provides current treatment practices, emerging drugs, Adeno

Seborrhoeic Dermatitis Clinical Trials | A Drug Pipeline Analysis Report 2024 | …

DelveInsight's 'Seborrhoeic Dermatitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Seborrhoeic Dermatitis therapies in various stages of clinical development,

Secondary Progressive Multiple Sclerosis Clinical Trials | A Drug Pipeline Analy …

DelveInsight's 'Secondary Progressive Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Secondary Progressive Multiple Sclerosis therapies in various

Sensorineural Hearing Loss Clinical Trials | A Drug Pipeline Analysis Report 202 …

DelveInsight's 'Sensorineural Hearing Loss Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sensorineural Hearing Loss therapies in various stages of

Raynaud's Disease Clinical Trials, Key Companies, Emerging Therapies | A Drug Pi …

DelveInsight's 'Raynaud's Disease Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Raynaud's Disease therapies in various stages of clinical development,

Ulcerative Colitis Clinical Trials | A Drug Pipeline Analysis Report 2024 | Oppi …

DelveInsight's 'Ulcerative Colitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Ulcerative Colitis therapies in various stages of clinical development,

Breast Cancer Biomarker Market Size in the 7MM was ~USD 7,400 Million in 2022, e …

DelveInsight's "Breast Cancer Biomarker Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of Breast Cancer Biomarker, historical and forecasted epidemiology

Amyotrophic Lateral Sclerosis Market Size in the 7MM was ~ USD 1,000 Million in …

DelveInsight's "Amyotrophic Lateral Sclerosis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of ALS, historical and forecasted epidemiology as well

Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline 2024: Clinical Tri …

DelveInsight's, "AAV Vectors in Gene Therapy Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 235+ pipeline drugs in AAV vectors in gene

CAR-T Pipeline Analysis 2024: Clinical Trials, FDA, EMA, and PMDA Approvals, Eme …

DelveInsight's, "CAR-T Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 460+ pipeline drugs in the CAR-T pipeline landscape. It covers the pipeline

Colorectal Cancer Pipeline Analysis, 2024: Clinical Trials, FDA, EMA, and PMDA A …

DelveInsight's, "Colorectal Cancer Pipeline Insight 2024" report provides comprehensive insights about 195+ companies and 200+ pipeline drugs in Colorectal Cancer pipeline landscape. It covers the

Advanced Renal Cell Carcinoma Pipeline 2024 | Merck Sharp & Dohme, Chia Tai Tian …

DelveInsight's, "Advanced Renal Cell Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline

Advanced Gastric Carcinoma Pipeline 2024 | Jiangsu Hengrui Medicine, BeiGene, CS …

DelveInsight's, "Advanced Gastric Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Advanced Gastric Carcinoma pipeline landscape. It

Hepatocellular Carcinoma Pipeline 2024

DelveInsight, "Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the

HER2 Positive Breast Cancer Pipeline Drugs 2024

DelveInsight's, "HER2 Positive Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 60+ companies and 65+ pipeline drugs in HER2 Positive Breast Cancer pipeline

Brain Metastasis from Breast Cancer Pipeline 2024 | Angiochem Inc., Novartis, Me …

DelveInsight's, "Brain Metastasis from Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Brain Metastasis from Breast

Go To Page:    41 42 43 44 45 46 47 48 49 50